Disciplined Growth Investors Inc Cara Therapeutics, Inc. Transaction History
Disciplined Growth Investors Inc
- $4.73 Billion
- Q3 2024
A detailed history of Disciplined Growth Investors Inc transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Disciplined Growth Investors Inc holds 1,113,043 shares of CARA stock, worth $511,999. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,113,043
Previous 1,935,718
42.5%
Holding current value
$511,999
Previous $503,000
31.41%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding CARA
# of Institutions
74Shares Held
12.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.25MShares$1.03 Million0.0% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$782,9700.06% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$715,8750.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.11MShares$510,1080.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny866KShares$398,4980.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $24.7M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...